Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANAB
ANAB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANAB News
AnaptysBio Completes Spin-Off, Focuses on Royalty Management
15h ago
Newsfilter
AnaptysBio Completes Spinoff of First Tracks Biotherapeutics
10h ago
seekingalpha
ANAPTYS FINALIZES DIVESTITURE OF FIRST TRACKS BIOTHERAPEUTICS AND NOW FOCUSES SOLELY ON GSK AND VANDA FINANCIAL PARTNERSHIPS
15h ago
moomoo
AnaptysBio Approves Spin-Off of First Tracks Biotherapeutics
Mar 27 2026
seekingalpha
AnaptysBio Announces $100 Million Buyback and Business Update
Mar 27 2026
NASDAQ.COM
Anaptys Announces Spin-Off of Biopharma Operations
Mar 27 2026
Newsfilter
First Tracks Biotherapeutics Secures $145 Million in Private Placement Financing
Mar 27 2026
Newsfilter
First Tracks Biotherapeutics Spin-Off Date Set
Mar 27 2026
Newsfilter
ANAPTYSBIO INC - AJIM TAMBOLI LIKELY TO BE NAMED CFO OF FIRST TRACKS BIO
Mar 27 2026
moomoo
ANAPTYSBIO INC TO SEPARATE BIOPHARMA OPERATIONS INTO FIRST TRACKS BIOTHERAPEUTICS ON APRIL 20, 2026
Mar 27 2026
moomoo
AnaptysBio Q4 Earnings Exceed Expectations
Mar 03 2026
seekingalpha
AnaptysBio Options Trading Analysis
Mar 03 2026
NASDAQ.COM
Vanda Pharmaceuticals Files BLA for Imsidolimab to Treat GPP
Feb 25 2026
PRnewswire
Vanda Pharmaceuticals Files BLA for Imsidolimab to Treat GPP
Feb 25 2026
Newsfilter
Anaptysbio Biotech Stock Breaks Trendline
Feb 03 2026
Yahoo Finance
AnaptysBio Director Sells 3,900 Shares for $193,342.50
Jan 12 2026
NASDAQ.COM
Show More News
